Seattle Genetics (SGEN) PT Raised to $165 at Stifel After Considering Merck Contribution
Tweet Send to a Friend
Stifel analyst Stephen Willey raised the price target on Seattle Genetics (NASDAQ: SGEN) to $165.00 (from $145.00) after updating the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
